Breaking News Instant updates and real-time market news.

STOK

Stoke Therapeutics

$21.63

0.195 (0.91%)

12:25
10/09/19
10/09
12:25
10/09/19
12:25

Stoke Therapeutics participates in a conference call with JPMorgan

SMid Biotechnology Analyst Fye holds a conference call with CEO Kaye on October 9 at 1 pm hosted by JPMorgan.

  • 09

    Oct

STOK Stoke Therapeutics
$21.63

0.195 (0.91%)

07/15/19
JPMS
07/15/19
INITIATION
Target $34
JPMS
Overweight
Stoke Therapeutics initiated with an Overweight at JPMorgan
JPMorgan analyst Jessica Fye started Stoke Therapeutics with an Overweight rating and $34 price target. The analyst has a positive view of the company's proprietary platform, Targeted Augmentation of Nuclear Gene Output, which modulates pre-mRNA splicing to increase protein expression. She believes TANGO enables a differentiated approach to target genetically driven diseases.
07/15/19
ADAM
07/15/19
INITIATION
Target $44
ADAM
Buy
Stoke Therapeutics initiated with a Buy at Canaccord
Canaccord analyst Michelle Gilson initiated Stoke Therapeutics with a Buy rating as she views its TANGO platform as a paradigm-changing technology to generate disease modifying therapeutics for disorders of autosomal dominant haploinsufficiency. The analyst views its STK-001 program for treatment of Dravet Syndrome as the best way to target the underlying genetic abnormality. Gilson has a $44 price target on Stoke Therapeutics shares.
07/15/19
COWN
07/15/19
INITIATION
COWN
Outperform
Stoke Therapeutics initiated with an Outperform at Cowen
Cowen analyst Yaron Werber imitated Stoke Therapeutics with an Outperform rating citing its TANGO platform which he said can target multiple indications that have few therapeutic options, allowing it to develop a deep and differentiated pipeline with its first mover advantage.
07/15/19
FBCO
07/15/19
INITIATION
Target $35
FBCO
Outperform
Stoke Therapeutics initiated with an Outperform at Credit Suisse
Credit Suisse analyst Martin Auster started coverage of Stoke Therapeutics with an Outperform rating and $35 price target. Noting that Stoke's lead asset, STK-001, is in development for Dravet syndrome, the analyst argues that the drug's intuitive mechanism of action and its demonstrated "strong" improvement in survival in a Dravet mouse model supports optimism for the program. Auster expects initial clinical results in 2021 and thinks that, despite the early stage nature of the story, a rapid and meaningful de-risking of the clinical program based on proof-of-concept data from a small number of patients is possible, based on early clinical results, which may lead to significant share appreciation.

TODAY'S FREE FLY STORIES

CE

Celanese

$121.37

-0.3 (-0.25%)

16:31
10/21/19
10/21
16:31
10/21/19
16:31
Earnings
Celanese reports Q3 adjusted EPS $2.53, consensus $2.51 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

OBE

Obsidian Energy

$0.70

(0.00%)

16:30
10/21/19
10/21
16:30
10/21/19
16:30
Hot Stocks
Obsidian Energy CFO David Hendry resigns »

Obsidian Energy said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWAV

ShockWave Medical

$33.98

1.68 (5.20%)

16:30
10/21/19
10/21
16:30
10/21/19
16:30
Initiation
ShockWave Medical initiated  »

ShockWave Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

16:30
10/21/19
10/21
16:30
10/21/19
16:30
Options
Preliminary option volume of 16.2M today »

Preliminary option volume…

TCMD

Tactile Systems

$46.66

-0.42 (-0.89%)

16:29
10/21/19
10/21
16:29
10/21/19
16:29
Initiation
Tactile Systems initiated  »

Tactile Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

SAGE

Sage Therapeutics

$140.90

0.9 (0.64%)

16:29
10/21/19
10/21
16:29
10/21/19
16:29
Conference/Events
Sage Therapeutics management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 12

    Nov

NVRO

Nevro

$85.85

0.88 (1.04%)

16:27
10/21/19
10/21
16:27
10/21/19
16:27
Initiation
Nevro initiated  »

Oppenheimer starts Nevro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

WSFS

WSFS Financial

$44.14

0.02 (0.05%)

16:26
10/21/19
10/21
16:26
10/21/19
16:26
Earnings
WSFS Financial reports Q3 EPS 98c, consensus 87c »

Net interest income in 3Q…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

QTNT

Quotient

$8.13

-0.33 (-3.90%)

16:25
10/21/19
10/21
16:25
10/21/19
16:25
Conference/Events
Quotient management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 04

    Nov

HXL

Hexcel

$74.60

-1.61 (-2.11%)

, BA

Boeing

$331.09

-13 (-3.78%)

16:25
10/21/19
10/21
16:25
10/21/19
16:25
Hot Stocks
Hexcel CEO sees further uncertainty related to Boeing 737 Max return to service »

CEO Nick Stanage states:…

HXL

Hexcel

$74.60

-1.61 (-2.11%)

BA

Boeing

$331.09

-13 (-3.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

XAIR

Beyond Air

$4.32

(0.00%)

16:25
10/21/19
10/21
16:25
10/21/19
16:25
Initiation
Beyond Air initiated  »

Oppenheimer starts Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRTC

iRhythm

$66.11

-3.22 (-4.64%)

16:25
10/21/19
10/21
16:25
10/21/19
16:25
Initiation
iRhythm initiated  »

iRhythm initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HXL

Hexcel

$74.60

-1.61 (-2.11%)

16:24
10/21/19
10/21
16:24
10/21/19
16:24
Hot Stocks
Hexcel reports Q3 gross margin 27.6% vs. $26.5% last year »

Reports Q3 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

VCYT

Veracyte

$26.18

1.52 (6.16%)

16:23
10/21/19
10/21
16:23
10/21/19
16:23
Hot Stocks
Veracyte says Percepta GSC clinical data results 'inconclusive' »

Veracyte announced data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Dec

CRVS

Corvus Pharmaceuticals

$3.50

-0.11 (-3.05%)

16:23
10/21/19
10/21
16:23
10/21/19
16:23
Conference/Events
Corvus Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

HXL

Hexcel

$74.60

-1.61 (-2.11%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Earnings
Hexcel backs FY19 EPS view $3.43-$3.53 , consensus $3.54 »

Backs FY19 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AHT

Ashford Hospitality

$2.94

0.01 (0.34%)

, BHR

Braemar Hotels & Resorts

$9.37

0.225 (2.46%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Hot Stocks
Braemar Hotels & Resorts declares distribution of shares of Ashford »

Braemar Hotels &…

AHT

Ashford Hospitality

$2.94

0.01 (0.34%)

BHR

Braemar Hotels & Resorts

$9.37

0.225 (2.46%)

AINC

Ashford

$22.33

-0.13 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 12

    Nov

VREX

Varex Imaging

$29.17

0.45 (1.57%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Initiation
Varex Imaging initiated  »

Oppenheimer starts Varex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRY

CryoLife

$24.00

0.32 (1.35%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Initiation
CryoLife initiated  »

CryoLife initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

SITC

Site Centers

$15.26

0.165 (1.09%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Syndicate
Site Centers files to sell 10.5M shares of common stock »

Goldman Sachs and Morgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 11

    Nov

  • 12

    Nov

HXL

Hexcel

$74.60

-1.61 (-2.11%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Earnings
Hexcel cuts FY19 revenue view to $2.34B-$2.40B from $2.38B-$2.48B 

Consensus $2.43B.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FCX

Freeport McMoRan

$9.82

0.245 (2.56%)

, T

AT&T

$38.23

-0.23 (-0.60%)

16:21
10/21/19
10/21
16:21
10/21/19
16:21
Hot Stocks
Freeport-McMoRan names AT&T CFO to board »

Freeport-McMoRan (FCX)…

FCX

Freeport McMoRan

$9.82

0.245 (2.56%)

T

AT&T

$38.23

-0.23 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 18

    Nov

  • 19

    Nov

HXL

Hexcel

$74.60

-1.61 (-2.11%)

16:21
10/21/19
10/21
16:21
10/21/19
16:21
Earnings
Hexcel reports Q3 EPS 90c, consensus 88c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

SITC

Site Centers

$15.26

0.165 (1.09%)

16:20
10/21/19
10/21
16:20
10/21/19
16:20
Earnings
Site Centers reports preliminary Q3 OFF 30c, consensus 28c »

Estimates 1.6% same store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 11

    Nov

  • 12

    Nov

KDMN

Kadmon

$3.08

0.17 (5.84%)

16:20
10/21/19
10/21
16:20
10/21/19
16:20
Hot Stocks
Kadmon announces FDA approval for Clovique »

Kadmon announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.